MENU
IMMX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Immix Biopharma (IMMX) Earnings Date & Reports

Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications... Show more

A.I. Advisor
published Earnings

IMMX is expected to report earnings to fall 20.83% to -18 cents per share on February 25

Immix Biopharma IMMX Stock Earnings Reports
Q4'25
Est.
$-0.19
Q3'25
Missed
by $0.08
Q2'25
Missed
by $0.01
Q1'25
Beat
by $0.08
Q4'24
Est.
$-0.25
The last earnings report on December 03 showed earnings per share of -23 cents, missing the estimate of -15 cents. With 1.55M shares outstanding, the current market capitalization sits at 372.56M.
View a ticker or compare two or three
IMMX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. IMMX showed earnings on December 03, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
11400 West Olympic Boulevard
Phone
+1 310 651-8041
Employees
17
Web
https://www.immixbio.com